K Nishio, M Sakurai, T Kusuyama, M Shigemitsu, T … - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—A total of 28 patients were randomly assigned to the control group, and 26 patients
were assigned to the pioglitazone group. There were no significant differences in glycemic control
levels or in lipid levels in the two groups at baseline or at follow-up. Insulin, homeostasis ... Cited by 60 - Related articles - BL Direct - All 6 versions
A Osman, J Otero, A Brizolara, S Waxman, G Stouffer, … - American Heart Journal, 2004 - Elsevier Patients with treated type 2 diabetes (mean duration 5.5 ± 7.5 years) referred for coronary stenting
were randomized in a double-blind fashion to receive oral rosiglitazone or placebo for 6
months. Quantitative coronary angiography and intravascular ultrasound data were ... Cited by 57 - Related articles - All 8 versions
- ►ahajournals.org N Marx, J Wohrle, T Nusser, D Walcher, A Rinker, V … - Circulation, 2005 - Am Heart Assoc Methods and Results— Fifty nondiabetic patients after coronary stent implantation were randomly
assigned to pioglitazone (30 mg daily; pio) or placebo (control) treatment in addition to standard
therapy, and neointima volume was assessed by intravascular ultrasound at the 6-month ... Cited by 121 - Related articles - All 8 versions
DM Riche, R Valderrama, NN Henyan - Diabetes Care, 2007 - Am Diabetes Assoc OBJECTIVE—Thiazolidinediones (TZDs) (rosiglitazone and pioglitazone) are a class of antidiabetes
agents that have a high affinity for peroxisome proliferator–activated receptor-γ. TZDs initiate
a multitude of physiologic processes that may elicit benefits as systemic agents for the ... Cited by 26 - Related articles - All 6 versions
D Choi, SK Kim, SH Choi, YG Ko, CW Ahn, Y Jang, … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—Eighty-three patients (45 patients with 55 lesions in the control group and 38 patients
with 51 lesions in the rosiglitazone group) completed follow-up angiography. Rosiglitazone treatment
for 6 months reduced fasting insulin concentration. The high-sensitivity C-reactive protein ... Cited by 216 - Related articles - BL Direct - All 8 versions
ES Rosmarakis, ME Falagas - American Heart Journal, 2007 - Elsevier Five RCTs that included 235 evaluable patients who underwent coronary stent implantation and
received a 6-month pioglitazone or rosiglitazone therapy were included in our
meta-analysis. Restenosis rate was significantly lower in patients who received ... Cited by 21 - Related articles - All 39 versions
G Wang, J Wei, Y Guan, N Jin, J Mao, X Wang - Metabolism, 2005 - Elsevier Rosiglitazone, an agonist of peroxisome proliferator–activated receptor-γ (PPARγ), is an
insulin-sensitizing antidiabetic agent and inhibits restenosis in animal blood vessels.
However, its benefit for patients with type 2 diabetes and coronary artery disease (CAD) ... Cited by 44 - Related articles - All 8 versions
T Takagi, A Yamamuro, K Tamita, K Yamabe, M … - American Heart Journal, 2003 - Elsevier To determine whether pioglitazone reduces neointimal tissue proliferation after coronary stent
implantation in patients with type 2 diabetes mellitus, we studied 44 stented lesions in 44 patients
with diabetes mellitus who underwent successful coronary stent implantation. Study ... Cited by 141 - Related articles - All 9 versions
T Katayama, H Ueba, K Tsuboi, N Kubo, T Yasu, M … - American Heart Journal, 2007 - Elsevier Twenty-eight nondiabetic patients with MS after bare-metal stent implantation were randomized
to 6-month treatment with or without 30 mg/d of pioglitazone (pioglitazone group [PIO] of 14 patients
with 16 lesions and control group [CONT] of 14 patients with 16 lesions). At baseline and ... Cited by 11 - Related articles - All 27 versions
H Sourij, R Zweiker, TC Wascher - Diabetes Care, 2006 - Am Diabetes Assoc OBJECTIVE—About one of five patients with coronary artery disease (CAD) suffers from previously
unknown, predominantly postprandial type 2 diabetes. In the process of atherogenesis and the
subsequent increased cardiovascular mortality of diabetic patients, endothelial ... Cited by 38 - Related articles - BL Direct - All 8 versions
